STAT
STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks
An FDA advisory panel has endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer.
Matthew Herper
Rights: fair use excerpt
---
Matthew Herper · STAT News · Photo: Grail
Source & Credit
Reporting and photography credited as noted above. Originally published by STAT News.
Members only
Checking your membership…